— slone (@slone) June 20, 2014
A drug approved by the FDA to treat rheumatoid arthritis has reportedly been used to successfully regrow a bald man’s hair.
The Daily News reports that the 25-year-old patient has alopecia universalis, resulting in nearly complete baldness on his head and body.
The Latest News Headlines, Traffic and Weather: Follow @news92fm
Scientists gave the patient tofacitinib citrate, made by Pfizer under the brand name Xeljanz, and it’s reported that he now has a full head of hair.
The patient took 10mg per day for two months followed by 15mg per day for another three months.
By the end, he’d completely regrown scalp hair, developed eyebrows, eyelashes and facial hair, armpit hair and other hair.
“By eight months there was full regrowth of hair,” said co-author Brittany G. Craiglow, M.D. “The patient has reported feeling no side effects, and we’ve seen no lab test abnormalities, either.”
Scientists believe the drug works by turning off the immune attack on hair follicles.